Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00054210

Public ClinicalTrials.gov record NCT00054210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 12:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of PS = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study

Study identification

NCT ID
NCT00054210
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CTI BioPharma
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • carboplatin Drug
  • paclitaxel Drug
  • paclitaxel poliglumex Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2002
Primary completion
Sep 30, 2004
Completion
Sep 30, 2004
Last update posted
Oct 4, 2020

2003 – 2004

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
34
Facility City State ZIP Site status
Hematology and Oncology Associates of Alabama Birmingham Alabama 35243
Clinical Research Consultants, Inc Hoover Alabama 35216
Arizona Clinical Research Center Tucson Arizona 85712
Synergy Hematology/Oncology Medical Associates Encino California 91316
Holy Cross Providence Cancer Center Mission Hills California 91345
Clinical Trials and Research Associates, Incorporated Montebello California 90640
California Hematology/Oncology Medical Group Torrance California 90505
Hematology Oncology, P.C. Stamford Connecticut 06902
New Hope Cancer Centers Hudson Florida 34667
Omni Healthcare, PA Melbourne Florida 32901
MetCare Oncology Ormond Beach Florida 32174
Hematology Oncology Associates of theTreasure Coast - Port St. Lucie Port Saint Lucie Florida 34952
Northwest Georgia Oncology Centers, P.C. Marietta Georgia 30060
Georgia Cancer Specialists - Tucker Tucker Georgia 30084
Silver Cross Hospital Joliet Illinois 60432
Gross Point Medical Center Skokie Illinois 60077
Kentucky Cancer Clinic Pikeville Kentucky 41501
Not listed Grand Rapids Michigan 49503
Hattiesburg Clinic, P.A. Hattiesburg Mississippi 39401
Columbia Comprehensive Cancer Care Clinic Columbia Missouri 65201
Bond Clinic Rolla Missouri 65401
Las Vegas Cancer Center Las Vegas Nevada 89102
Summit Medical Group, P.A. Summit New Jersey 07901
Gabrail Cancer Center - Canton Office Canton Ohio 44718
Oklahoma Oncology, Inc. - St. John Campus Tulsa Oklahoma 74104
Charleston Cancer Center Charleston South Carolina 29406
Santee Hematology Oncology Sumter South Carolina 29150
Clarksville Regional Hematology/Oncology Group Clarksville Tennessee 37043
Family Cancer Center Collierville Tennessee 38017
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009
Cancer Therapy and Research Center San Antonio Texas 78229
Virginia Oncology Care P.C. Richlands Virginia 24641
Highline Medical Oncology Burien Washington 98166
Rainier Oncology Puyallup Washington 98372

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00054210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 4, 2020 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00054210 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →